Artbio announced $23 million seed financing led by F-Prime Capital with Omega Funds.

Health services Manufacturing Pharma

Norway

United States

Investments

21 June 2023

Share:

Artbio (company)

Norway

Health services Manufacturing Pharma

Total investments received (USD): 245m

Round value (USD): 23m

Round investors: F-Prime Capital Omega Funds

Company: Artbio

Industry: Health services Manufacturing Pharma

Related deals

Vandria in a CHF18 million series A round led by ND Capital together with a small syndicate of HNW private investors.

Biotech Health services Manufacturing Pharma

Switzerland

United States

Investments 15 December 2023

LUMA Vision raises €20M in another series A extension w/ EQT Life Sciences, ABV Uni Fund and imec.xpand

Hardware Health services Manufacturing Software Services

Ireland

Germany

Sweden

Belgium

Investments 10 December 2023

Freya raised $38m in Series A round co-led by Sofinnova and OMX, with EIFO, Angelini Ventures, Mike Jafar Family Office, CE-Ventures, Corundum, Indaco

Biotech Health services Manufacturing

Denmark

Italy

France

United States

United Arab Emirates

Japan

Investments 07 December 2023

Apollo Therapeutics raised $33.5m in an extended Series C funding led by Patient Square Capital, joined by M&G and Rock Springs Capital.

Biotech Manufacturing Pharma

United Kingdom

United States

Investments 03 December 2023

ViaNautis to raise £20M series A with UCB Ventures, BGF Ventures, 4BIO Capital

Biotech Health services Manufacturing Pharma

United Kingdom

Belgium

Investments 10 November 2023